Back

IGFBP7 is associated with markers of subclinical myocardial damage in patients with stable ischemic heart disease.

13 April 2019 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster Session 3 - Chronic Heart Failure Chronic Heart Failure, Other EAPC Premium Access EuroPrevent 2019

About the speaker

Photo
Doctor Inga Kaminska

Bialystok (Poland)

37 More presentations in this session

Presentation thumbnail
Doctor Y. Obata (Sapporo, JP)
Abstract
Presentation thumbnail
Mr C. Kourek (Wynnewood, US)
Abstract Slides
Presentation thumbnail
Doctor E. Karatzanos (Athens, GR)
Abstract Slides
Presentation thumbnail
Miss S. Remmelzwaal (Amsterdam, NL)
Abstract Slides
Presentation thumbnail
Ms S. Lima Cavalcante (Porto, PT)
Abstract

Access the full session

Session thumbnail
Poster Session 3 - Chronic Heart Failure

The Event

Event poster

EuroPrevent 2019

13 April 2019 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Association of insulin-like growth factor-binding protein-7 levels with the presence and severity of hypertensive heart disease in patients with arterial hypertension and abdominal obesity
28 August 2026
thumbnail
Congress Presentation
Prognostic significance of novel serum biomarkers in patients with acute coronary syndrome
27 August 2021
thumbnail
Congress Presentation
Relationship of myocardial fibrosis markers with cardiac structural and functional parameters in patients with post-myocardial infarction.
29 June 2021
thumbnail
Congress Presentation
Vitamin D binding protein as a potential biomarker for heart failure in myocarditis: Translational animal model reveals mechanism
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources